AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17505700 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive (15 microg ethinyl estradiol/60 microg gestodene)
Number of subjects: 20
Study 17505700 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 16422247 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART (Highly Active Antiretroviral Therapy)
Number of subjects: 20
Study 11932759 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-month regimen of anti-tuberculous drugs (NTCP recommended)
Number of subjects: 550
Study 11932759 — intervention group
Group type: COMPARATOR
Intervention: 6-month regimen of anti-tuberculous drugs
Number of subjects: 550
Study 9617982 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 20 mg
Number of subjects: 31
Study 9617982 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 30 mg
Number of subjects: 31
Study 9617982 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine 20 mg
Number of subjects: 31
Study 9617982 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine 30 mg
Number of subjects: 31
Study 9617982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 9617982 — intervention group
Group type: COMPARATOR
Intervention: Dextroamphetamine (both doses)
Number of subjects: 31
Study 7847110 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailing a postcard listing required immunizations followed by telephone contact
Number of subjects: 464
Study 7847110 — intervention group
Group type: COMPARATOR
Intervention: Control group (no contact)
Number of subjects: 464
Study 2681856 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 185
Study 2681856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 1205340 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole and acetylsalicylic acid
Number of subjects: 60
Study 1205340 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of heparin
Number of subjects: 60
Study 1205340 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 30293457 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic elastomeric fabric orthosis 2 h group
Number of subjects: 24
Study 30293457 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic elastomeric fabric orthosis 6 h group
Number of subjects: 24
Study 30293457 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional exercise therapy)
Number of subjects: 24
Study 30293457 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic elastomeric fabric orthosis 2 h and 6 h groups
Number of subjects: 24
Study 30293457 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic elastomeric fabric orthosis groups
Number of subjects: 24
Study 30293457 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 30976782 — intervention group
Group type: COMPARATOR
Intervention: Baseline portion size
Number of subjects: 46
Study 30976782 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased portion size (50% larger)
Number of subjects: 46
Study 28374832 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based approach (group A)
Number of subjects: 172
Study 28374832 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based approach (group B)
Number of subjects: 172
Study 26067429 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet-ice application
Number of subjects: 54
Study 26067429 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion
Number of subjects: 54
Study 26067429 — intervention group
Group type: COMPARATOR
Intervention: Untreated control condition
Number of subjects: 54
Study 23008177 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI with MGuard stent
Number of subjects: 432
Study 23008177 — intervention group
Group type: COMPARATOR
Intervention: PCI using bare metal or drug-eluting stents (control arm)
Number of subjects: 432
Study 23008177 — intervention group
Group type: EXPERIMENTAL
Intervention: MGuard stent
Number of subjects: 432
Study 21287564 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (1-Hz, 1800 pulses at 110% of motor threshold)
Number of subjects: 0
Study 21287564 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 0
Study 21287564 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 0
Study 19185633 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nesiritide
Number of subjects: 7000
Study 19185633 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 7000
Study 16733496 — intervention group
Group type: COMPARATOR
Intervention: Budesonide 9 mg/day (group A)
Number of subjects: 30
Study 16733496 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) 10 mg/day (group B)
Number of subjects: 30
Study 16733496 — intervention group
Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 30
Study 16733496 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (group A)
Number of subjects: 30
Study 16733496 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) (group B)
Number of subjects: 30
Study 15274762 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0
Study 15274762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11379400 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alpha (10,000 U subcutaneously, thrice weekly)
Number of subjects: 90
Study 11379400 — intervention group
Group type: COMPARATOR
Intervention: Historical control group (cisplatin and gemcitabine without epoetin alpha)
Number of subjects: 90
Study 11379400 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alpha group
Number of subjects: 90
Study 11379400 — intervention group
Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 90
Study 11379400 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alpha
Number of subjects: 90
Study 9394640 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-gender teams (all men)
Number of subjects: 40
Study 9394640 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-gender teams (all women)
Number of subjects: 40
Study 9394640 — intervention group
Group type: COMPARATOR
Intervention: Mixed-gender teams
Number of subjects: 40
Study 9394640 — intervention group
Group type: EXPERIMENTAL
Intervention: Team size (2, 3, 4 persons)
Number of subjects: 40
Study 7955813 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg felbamate twice a day
Number of subjects: 10
Study 7955813 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg felbamate twice a day
Number of subjects: 10
Study 7955813 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of felbamate (600 mg and 1200 mg)
Number of subjects: 10
Study 3653463 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% domoprednate
Number of subjects: 39
Study 3653463 — intervention group
Group type: COMPARATOR
Intervention: hydrocortisone butyrate
Number of subjects: 39
Study 3653463 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient preference for treatment
Number of subjects: 39
Study 3653463 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolerance of treatments
Number of subjects: 39
Study 28951236 — intervention group
Group type: EXPERIMENTAL
Intervention: Showing the pork roast with the head present
Number of subjects: 0
Study 28951236 — intervention group
Group type: COMPARATOR
Intervention: Showing the pork roast with the head removed
Number of subjects: 0
Study 28951236 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissociation mechanism
Number of subjects: 0
Study 28951236 — intervention group
Group type: EXPERIMENTAL
Intervention: Disgust and empathy
Number of subjects: 0
Study 27733193 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intensive lifestyle program aimed at achieving weight loss
Number of subjects: 260
Study 27733193 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based enhanced diabetes self-management program
Number of subjects: 260
Study 25675558 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 60
Study 25675558 — intervention group
Group type: COMPARATOR
Intervention: Medication (nimodipine and fluoxetine)
Number of subjects: 60
Study 23754711 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/day for 6 weeks
Number of subjects: 35
Study 23754711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 20429017 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 μA DC electrical stimulation
Number of subjects: 80
Study 20429017 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 μA DC electrical stimulation
Number of subjects: 80
Study 20429017 — intervention group
Group type: COMPARATOR
Intervention: Control group (uninstrumented posterolateral fusion)
Number of subjects: 80
Study 20429017 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (fusion mass BMD)
Number of subjects: 80
Study 20429017 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking status
Number of subjects: 80
Study 20429017 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 80
Study 18726596 — intervention group
Group type: EXPERIMENTAL
Intervention: Central histopathology review
Number of subjects: 0
Study 16011133 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual technique
Number of subjects: 50
Study 16011133 — intervention group
Group type: COMPARATOR
Intervention: One‐handed technique
Number of subjects: 50
Study 14742935 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized field external radiotherapy 50 Gy/25#/5 wks followed by Boost 10 Gy/5#/1 wk
Number of subjects: 50
Study 14742935 — intervention group
Group type: COMPARATOR
Intervention: Whole brain external radiotherapy 40 Gy/20#/4 wks followed by Boost 20 Gy/10#/2 wks
Number of subjects: 50
Study 14742935 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized field external radiotherapy
Number of subjects: 50
Study 14742935 — intervention group
Group type: COMPARATOR
Intervention: Whole brain external radiotherapy
Number of subjects: 50
Study 11037003 — intervention group
Group type: EXPERIMENTAL
Intervention: EGb 761 (ginkgo) 240 mg/day or 160 mg/day
Number of subjects: 214
Study 11037003 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg/d)
Number of subjects: 214
Study 8688261 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 50 micrograms kg‐1
Number of subjects: 22
Study 8688261 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 22
Study 1840038 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐ANP 0.3 micrograms.kg‐1 bwt
Number of subjects: 40
Study 1840038 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐ANP 1.5 micrograms.kg‐1 bwt
Number of subjects: 40
Study 1840038 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐ANP 3.0 micrograms.kg‐1 bwt
Number of subjects: 40
Study 1840038 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐ANP
Number of subjects: 40
Study 1840038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 6126068 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 0.4 mg
Number of subjects: 1
Study 6126068 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 1
Study 31445873 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood ADHD
Number of subjects: 680
Study 31445873 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult ADHD symptom persistence
Number of subjects: 680
Study 31445873 — intervention group
Group type: COMPARATOR
Intervention: ADHD desistance
Number of subjects: 680
Study 31526415 — intervention group
Group type: EXPERIMENTAL
Intervention: External reward intervention
Number of subjects: 381
Study 31526415 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated threat perception intervention
Number of subjects: 381
Study 31526415 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of a cognitive cluster related to preparedness intervention
Number of subjects: 381
Study 31526415 — intervention group
Group type: COMPARATOR
Intervention: Control group 1
Number of subjects: 381
Study 31526415 — intervention group
Group type: COMPARATOR
Intervention: Control group 2
Number of subjects: 381
Study 28398166 — intervention group
Group type: EXPERIMENTAL
Intervention: Power priming condition
Number of subjects: 0
Study 28398166 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 25643051 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 Hz TEAS
Number of subjects: 60
Study 25643051 — intervention group
Group type: COMPARATOR
Intervention: 2 Hz TEAS
Number of subjects: 60
Study 25643051 — intervention group
Group type: COMPARATOR
Intervention: 0 Hz (sham) TEAS
Number of subjects: 60
Study 24237485 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive affect condition
Number of subjects: 120
Study 24237485 — intervention group
Group type: COMPARATOR
Intervention: Neutral affect condition
Number of subjects: 120
Study 24237485 — intervention group
Group type: COMPARATOR
Intervention: Negative affect condition
Number of subjects: 120
Study 24237485 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive flexibility (measured by a switch task)
Number of subjects: 120
Study 24237485 — intervention group
Group type: EXPERIMENTAL
Intervention: Divergent thinking
Number of subjects: 120
Study 21484517 — intervention group
Group type: EXPERIMENTAL
Intervention: Face expertise training
Number of subjects: 0
Study 21484517 — intervention group
Group type: COMPARATOR
Intervention: House training (Control)
Number of subjects: 0
Study 19501439 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa to increase hemoglobin levels to 13 g/dL
Number of subjects: 4044
Study 19501439 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4044
Study 17181457 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial constructs (self‐efficacy, decisional balance, social support, behavior change strategies)
Number of subjects: 441
Study 15887532 — intervention group
Group type: EXPERIMENTAL
Intervention: Support vector machines (SVM) for gait classification
Number of subjects: 58
Study 15887532 — intervention group
Group type: COMPARATOR
Intervention: Neural network for gait classification
Number of subjects: 58
Study 15887532 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait features extracted from MFC plots
Number of subjects: 58
Study 15821920 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous serum eye drops
Number of subjects: 23
Study 15821920 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid eye drops
Number of subjects: 23
Study 10232440 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial provocation with lysine-aspirin
Number of subjects: 28
Study 10172710 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 800 micrograms via Turbuhaler
Number of subjects: 0
Study 10172710 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) 1500 to 2000 micrograms via pressurized metered-dose inhaler with spacer
Number of subjects: 0
Study 1914375 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (150 ml)
Number of subjects: 9
Study 1914375 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (200 mg)
Number of subjects: 9
Study 1914375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 1914375 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 9
Study 6800251 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 19
Study 6800251 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 19
Study 6800251 — intervention group
Group type: COMPARATOR
Intervention: Lead-in phase
Number of subjects: 19
Study 29704147 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic marijuana users
Number of subjects: 662
Study 29704147 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasers (those who increased marijuana use)
Number of subjects: 662
Study 29704147 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasers (those who decreased marijuana use)
Number of subjects: 662
Study 29704147 — intervention group
Group type: COMPARATOR
Intervention: Abstainers
Number of subjects: 662
Study 29704147 — intervention group
Group type: EXPERIMENTAL
Intervention: Employment status and perceived workplace stress
Number of subjects: 662
Study 28846563 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with protein supplementation
Number of subjects: 36
Study 28846563 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 36
Study 27306539 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic weight‐bearing Assessment of Pain (DAP)
Number of subjects: 100
Study 25286913 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodynamically guided HF management using daily uploaded pressures
Number of subjects: 550
Study 25286913 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodynamically guided HF management
Number of subjects: 550
Study 25286913 — intervention group
Group type: COMPARATOR
Intervention: Standard HF management (control group)
Number of subjects: 550
Study 22311517 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 25
Study 22311517 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 25
Study 22311517 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen
Number of subjects: 25
Study 22311517 — intervention group
Group type: COMPARATOR
Intervention: PTH(1‐34) infusion
Number of subjects: 25
Study 20835586 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose inhaler (400 µg of MF once a day for 60 days)
Number of subjects: 74
Study 20835586 — intervention group
Group type: COMPARATOR
Intervention: Single-dose inhaler (400 µg of MF once a day for 60 days)
Number of subjects: 74
Study 17617901 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium as sodium selenite (4,000 microg on the first day, 1,000 microg/day for the next 9 days)
Number of subjects: 60
Study 17617901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 17617901 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium as sodium selenite
Number of subjects: 60
Study 16076379 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer 6.0 g/day (Group A)
Number of subjects: 62
Study 16076379 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer 3.0 g/day and Calcium Carbonate 3.0 g/day (Group B)
Number of subjects: 62
Study 16076379 — intervention group
Group type: COMPARATOR
Intervention: Calcium Carbonate 3.0 g/day (Group C)
Number of subjects: 62
Study 12163427 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone treatment
Number of subjects: 0
Study 10450630 — intervention group
Group type: EXPERIMENTAL
Intervention: Full Cognitive Therapy (FCT)
Number of subjects: 43
Study 10450630 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Cognitive Therapy (BCT)
Number of subjects: 43
Study 10450630 — intervention group
Group type: COMPARATOR
Intervention: Wait list
Number of subjects: 43
Study 7846788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium
Number of subjects: 2438
Study 7846788 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 2438
Study 31228015 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention
Number of subjects: 151
Study 30153598 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 71
Study 30153598 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg ketamine
Number of subjects: 71
Study 30153598 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 71
Study 27427877 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza/hepatitis B vaccination
Number of subjects: 26
Study 27427877 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcus/hepatitis B vaccination
Number of subjects: 26
Study 27427877 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination (combined effects)
Number of subjects: 26
Study 27427877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 24630742 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary negative symptoms
Number of subjects: 1427
Study 22362720 — intervention group
Group type: EXPERIMENTAL
Intervention: Suckling on a pacifier incorporated into a mask
Number of subjects: 12
Study 22362720 — intervention group
Group type: COMPARATOR
Intervention: Conventional mask
Number of subjects: 12
Study 19827463 — intervention group
Group type: EXPERIMENTAL
Intervention: Encapsulated antioxidant concentrate (EAC)
Number of subjects: 8
Study 19827463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 17719303 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 264
Study 17719303 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride alone
Number of subjects: 264
Study 17719303 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride plus oral NAC (600 mg bid)
Number of subjects: 264
Study 15212623 — intervention group
Group type: COMPARATOR
Intervention: Strontium ranelate 1000 mg/day
Number of subjects: 353
Study 15212623 — intervention group
Group type: COMPARATOR
Intervention: Strontium ranelate 2000 mg/day
Number of subjects: 353
Study 15212623 — intervention group
Group type: COMPARATOR
Intervention: Strontium ranelate 2000 mg
Number of subjects: 353
Study 15212623 — intervention group
Group type: COMPARATOR
Intervention: Strontium ranelate
Number of subjects: 353
Study 11456285 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine 5 g orally
Number of subjects: 12
Study 11456285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9604941 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 94
Study 9604941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 9604941 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 94
Study 9604941 — intervention group
Group type: COMPARATOR
Intervention: No Aspirin
Number of subjects: 94
Study 7809344 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term cognitive psychotherapy (10 sessions during 4 months)
Number of subjects: 100
Study 7809344 — intervention group
Group type: COMPARATOR
Intervention: Control group (no psychotherapy)
Number of subjects: 100